Today: 19 May 2026
GitLab Stock Rises After Anthropic Claude Deal as AI Tool Race Heats Up

GitLab Stock Rises After Anthropic Claude Deal as AI Tool Race Heats Up

SAN FRANCISCO, April 28, 2026, 08:58 PDT

  • GitLab is rolling out deeper integration of Claude models—like Claude Opus 4.7—across its Duo Agent Platform.
  • It’s a play for bigger firms seeking AI coding solutions—firms that aren’t willing to let go of audit tracking, policy oversight, or cloud contract wiggle room.
  • GitLab shares climbed Tuesday morning, but investors continue to have concerns about AI rivals and whether the company can deliver on sales.

GitLab Inc. on Tuesday announced it’s expanding its partnership with Anthropic, integrating the latest Claude models into the GitLab Duo Agent Platform. Enterprise users now get direct access to new Claude tools, with all agent activities still governed by GitLab’s compliance, audit, and policy frameworks.

Software vendors are scrambling to push “agentic AI” tools—AI that can handle specific tasks with a degree of independence—into the hands of engineering teams. GitLab is leaning hard on more than just speed. Their focus? Controlled coding. With companies questioning just how much power their AI should wield in source code, security vetting, and deployment pipelines, control is becoming the headline.

GitLab said enterprises now have access to Claude models—including Claude Opus 4.7—via Google Cloud and AWS Bedrock. That means customers can funnel AI workloads through their existing cloud contracts, keeping data residency policies intact. The company also noted it joined Claude Marketplace, so customers can use GitLab credits toward Anthropic spend commitments.

GitLab shares climbed roughly 3.2% to $22.14 early Tuesday, putting the company’s market cap near $3.71 billion. The stock hit an intraday peak of $23.19, market data showed.

GitLab is pitching the agreement as a move to embed security—DevSecOps-style—right in the development and operations workflow, not just as a last-minute audit. In its blog post, the company says Claude now runs several GitLab Duo functions: generating code, reviewing it, agentic chat, and even fixing vulnerabilities.

Mans Booijink, operations manager at Cube, said GitLab Duo let teams “plan, build, and ship software,” while keeping governance practices consistent. Sam Werboff, Anthropic’s head of enterprise go-to-market, pointed out that the expanded partnership brings Claude into GitLab Duo, complete with compliance and auditability tools that existing shared customers rely on. Business Wire

“Enterprises want stronger AI tools ‘without compromise,’” said Manav Khurana, GitLab’s chief product and marketing officer. That’s how the company sums up its pitch: AI agents need to be powerful, but still can’t slip past approvals, logs, or security protocols. Business Wire

According to GitLab’s documentation, Claude Opus 4.7 shows up as a supported model for GitLab Duo Agentic Chat, alongside other agents. That model-selection page also features a range of OpenAI models—highlighting GitLab’s push to position Duo as a platform that handles more than a single LLM provider.

Competition is stiff. GitLab flagged Microsoft—thanks to its ownership of GitHub—as its primary competitor in the most recent annual filing. Other names in the mix: DevOps offerings from Atlassian, JFrog, and Harness. The company also pointed to AI-assisted development as a reason the market should remain “intense.” SEC

Anthropic’s latest move comes after GitLab turned in a solid, if not spotless, financial year. Revenue for fiscal 2026 hit $955.2 million, climbing 26%, and annual recurring revenue topped $1 billion. The company still ended the year in the red on a GAAP basis, but went ahead with a $400 million buyback plan.

There’s a risk here: new product launches don’t always translate into immediate revenue gains. GitLab, for its part, has forecast fiscal 2027 revenue between $1.099 billion and $1.118 billion—growth, yes, but at a slower clip than in fiscal 2026. The big question is whether Duo can actually turn into a lasting engine for expansion, not just another AI tool tossed into an already crowded field.

BofA Securities dialed back its stance on GitLab last week, downgrading the stock to Neutral from Buy and slashing the price target to $27, down from $58, due to concerns over AI-driven competition and risks around execution. According to the firm, the key signal that GitLab’s agentic software-development push is making headway would be a renewed acceleration in revenue growth.

Stock Market Today

  • Australia Shares Rebound on US Delay of Iran Strikes and Renewed Peace Deal Prospects
    May 18, 2026, 10:36 PM EDT. Australia's benchmark shares rose sharply as the US postponed military strikes on Iran, boosting investor confidence. The move renewed hopes for a peaceful resolution to the long-standing conflict, easing geopolitical tensions that had weighed on markets. Optimism around de-escalation supported gains in energy and materials sectors, key drivers of Australia's stock market. The ASX 200 index recovered earlier losses, reflecting the positive response to developments in US-Iran relations. Investors remain cautious but encouraged by the prospect of diplomatic progress reducing regional instability.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Centene Stock Surges as 2026 Profit Forecast Gets a Medical-Cost Boost
Previous Story

Centene Stock Surges as 2026 Profit Forecast Gets a Medical-Cost Boost

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook
Next Story

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

Go toTop